Patents Assigned to Hunter Research Corporation
  • Patent number: 7229967
    Abstract: The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to O2 saturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: June 12, 2007
    Assignee: Hunter Research Corporation
    Inventor: Bernard V. Ecanow
  • Publication number: 20060105056
    Abstract: The compositions described herein comprise oxygenated albumin in an aqueous sterile physiological or serum solution. The albumin is oxygenated to increase the oxygen content up to O2 saturation with clinically useful oxygen gas. The preferred oxygen-saturated preparations, containing albumin in concentrations from about 5% w/v to about 25% w/v, are useful as clinical resuscitation preparations that release oxygen in a pattern similar to the release of oxygen by whole blood.
    Type: Application
    Filed: November 12, 2004
    Publication date: May 18, 2006
    Applicant: HUNTER RESEARCH CORPORATION
    Inventor: Bernard Ecanow
  • Patent number: 5382437
    Abstract: A readily dissolved carrier material having sufficient rigidity for administration of drugs, nutrients, vitamins, biologically-active materials, foodstuffs and combinations thereof capable of rapid dissolution by saliva, bodily fluids or other liquid comprising an interim skeletal structure of an ammoniated gel or foam forming material, preferably a proteinaceous material, such as gelatin, that has been ammoniated, rigidified such as with maltodextrin, in the ammoniated state and deammoniated to leave spaces in place of the frozen ammonia. On dissolution by saliva, bodily fluids or other liquids, the composition becomes a liquid system. While the oral route is preferred, other routes may be used to administer the compositions of this method.
    Type: Grant
    Filed: October 25, 1993
    Date of Patent: January 17, 1995
    Assignee: Hunter Research Corporation
    Inventor: Bernard Ecanow